Follow-up of vertically HIV-1-infected long-surviving children

AIDS Patient Care and STDs

Volumn 15, Issue 2, 2001, Pages 59-65

  Salvini, F ^a   Scarlatti, G ^b   Bossi, A ^c   Pinzani, R ^a   Zibordi, F ^d   Giovanettoni, C ^a   Plebani, A ^a  

^a Clinica Pediatrica De Marchi   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Istituto Neurologico   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; COTRIMOXAZOLE; DIDANOSINE; IMMUNOGLOBULIN; LAMIVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE DURATION; EYE MOVEMENT; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; PHENOTYPE; SCHOOL CHILD; SURVIVAL TIME; VERTICAL TRANSMISSION;

ADOLESCENT; CHILD; DISEASE TRANSMISSION, VERTICAL; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; MALE; PHENOTYPE;

EID: 0035101076     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729101300003645     Document Type: Article

References (30)

1. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection
2. Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age
3. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease
4. Natural history of vertically acquired human immunodeficiency virus-1 infection
5. Older children and adolescents living with perinatally acquired human immunodeficiency virus infection
6. Workshop on perinatally acquired immunodeficiency virus infection in long-term surviving children: A collaborative study of factors contributing to slow disease progression
7. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery
8. Biological features of HIV-1 that correlate with virulence in the host
9. Type 1 cytokine production and low prevalence of viral isolation correlate with long-term non progression in HIV infection
10. Viral counts count in HIV infection
11. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1 infected children
12. Viral load and disease progression in infants infected with human immunodeficiency virus type 1
13. Polymerase chain reaction, virus isolation and antigen assay in HIV-1 antibody positive mothers and their children
14. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother-to-child correlates with viral phenotype
15. In vivo evolution of HIV-1 coreceptor usage and sensitivity to chemokine-mediated suppression
16. Vertical HIV-1 infection involvement of the CNS and treatment
17. Unusual presentation and course of HIV-1 progressive encephalopathy
18. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child
19. Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus
20. Left ventricular structure and function in children infected with human immunodeficiency virus
21. Neurological and developmental problems in pediatric HIV
22. Characteristics of children surviving to 5 years of age or older with vertically acquired HIV infection
23. Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients
24. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection
25. Prognostic value of a CCR5 defective allele in paediatric HIV-1 infection
26. Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected children
27. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS
28. Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection
29. Morbidity and mortality in European children vertically infected by HIV-1
30. Natural history of human immunodeficiency virus disease in perinatally infected children: An analysis from the Pediatric Spectrum of Disease Project